Skip to content

Inspection Record

Innovative Transfusion Medicine, Inc. — FDA 483 Findings

US FDAInspected 2024-10-07Published 2026-10-20 4 findingsOther quality systemMaterial and supplier control

Inspectors Sergio E Delgado · Nerming V BrionesThe inspectors who signed the published document.Inspector lookup

View the regulator's official source The source document is always the basis for judgement.

Findings

1Other quality system

Failure to maintain general records.

2Material and supplier control

Failure to review all records required under the regulations to identify previously donated blood and blood components within 3 calendar days after a donor tests reactive for evidence of HIV infection indicating evidence of HIV infection.

3Material and supplier control

Written standard operating procedures including all steps to be followed in the collection, processing and storage of blood and blood components for further manufacturing purposes were not always followed.

4Material and supplier control

Failure to review all records required under the regulations to identify previously donated blood and blood components within 3 calendar days after a donor tests reactive for evidence ofHCV infection indicating evidence of HCV infection.

Similar findings at other companies

GRM selected findings from the same type of public document whose wording is close to a finding in this document. One per company.

A record as of the US FDA document published on 2026-10-20. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.

Innovative Transfusion Medicine, Inc. company profile — full historyAll US FDA findings US FDA documents, 2026 Go to Findings search
Weekly Newsletter

Get new findings like these every Monday

Every Monday we email the week's new findings and actions from the FDA, EMA, Health Canada and MFDS. Each one links to its record on our site, where you'll find the regulator's original document. We'll also let you know when the site gains new features. Unsubscribe any time with one click.

See recent findings first

Sent every Monday · a confirmation email follows when you subscribe · unsubscribe from the footer of any email.